This article illustrates various ways in which the term "dose" is used in the routine practice of nuclear pharmacy. In addition, various specialized doses are discussed, using radiolabeled monoclonal antibodies for illustration. Lastly, numerous considerations and factors affecting the dose of radiopharmaceuticals when used in infants and in children are identified and discussed relative to their impact on the benefit/ risk ratio.
Get full access to this article
View all access options for this article.
References
1.
Chilton HM, Witcofski RL: Nuclear Pharmacy: An Introduction to the Clinical Application of Radiopharmaceuticals . Philadelphia, Lea & Febiger , 1986
2.
Siddiqui AR: Nuclear Imaging in Pediatrics. Chicago, Year Book Medical , 1985
3.
Bell EG, McAfee JG, Subramanian G.: Radiopharmaceuticals in pediatrics, in James AE, Wagner HN, Cooke RE (eds): Pediatric Nuclear Medicine . Philadelphia, Saunders, 1974, pp 84-94
4.
Saenger EL, Kereiakes JG: Radiation biology, in James AE, Wagner HN, Cooke RE (eds): Pediatric Nuclear Medicine. Philadelphia , Saunders, 1974, pp 1-21
5.
Mitchell TG: Practical factors in radiation dose reduction, in James AE, Wagner HN, Cooke RE (eds): Pediatric Nuclear Medicine. Philadlphia, Saunders, 1974, pp 22-33
6.
Webster EW, Alpert NM, Brownell GL: Radiation doses in pediatric nuclear medicine and diagnostic x-ray procedures , in James AE, Wagner HN, Cooke RE (eds): Pediatric Nuclear Medicine. Philadelphia , Saunders, 1974, pp 34-58
7.
Kowalsky RJ, Perry JR: Radiopharmaceuticals in Nuclear Medicine Practice. Norwalk, CT, Appleton & Lange, 1987, pp 68-69
8.
Levine G., Tauxe WN, Kirkwood J., et al: Phase I-II Trial: Labeled Monoclonal Antibody to CEA in Patients with Colorectal Cancer. American Association ofClinical Oncology , New Orleans, May, 1988 (Exhibit)
9.
Ballou B., Reiland J., Levine G., et al: Tumor location with F(ab')2 from monoclonal antibody: Pharmacokinetics . J Nucl Med26:283-292, 1985
10.
Levine G., Ballou B., Reiland J., et al: Localization of 131I-labeled tumor specific monoclonal antibody in the tumor bearing BALB/C mouse. J Nucl Med21:510-513, 1980
11.
Ballou B., Levine G., Hakala T., et al: Tumor localization with radiolabeled monoclonal antibody using external scintigraphy. Science206:844-847, 1979
12.
Sartiano GP , Levine G.: Influence of Dimercaprol (BAL, 2,3-dimereapto-0-1-propanol) on the pharmacokinetics of 111In Bleomycin in the P-1798 lymphoma bearing BALB/C mouse. Int J Oncol39:120-125, 1980
13.
Levine G., Mazetti C., Malhi B.: A methodology for the preparation of pediatric doses of Tc-99m MAA for pulmonary perfusion studies. J Nucl Med Technol8:94-96, 1980
14.
Levine G., Malhi B.: Theoretical considerations in the preparation of 99mTc MAA for pulmonary perfusion studies. J Nucl Med Technol9:37-39, 1981
